These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 2460967

  • 1. Synergistic antiplatelet and antithrombotic effects of a prostacyclin analogue (iloprost) combined with a thromboxane antagonist (sulotroban) in guinea pigs and rats.
    Witt W, Stürzebecher S, Müller B.
    Thromb Res; 1988 Sep 15; 51(6):607-16. PubMed ID: 2460967
    [Abstract] [Full Text] [Related]

  • 2. The PGI2-analogue iloprost and the TXA2-receptor antagonist sulotroban synergistically inhibit TXA2-dependent platelet activation.
    Stürzebecher S, Witt W.
    Prostaglandins; 1988 Dec 15; 36(6):751-60. PubMed ID: 2469101
    [Abstract] [Full Text] [Related]

  • 3. Protective effects of the novel thromboxane A2 receptor antagonist sodium (E)-11-[2-(5,6-dimethyl-1-benzimidazolyl)-ethylidene]-6,11- dihydrodibenz[b,e]oxepine-2-carboxylate monohydrate against 9,11-dideoxy- 9 alpha, 11 alpha-epoxymethano-prostaglandin F2 alpha-induced sudden death in guinea-pigs and rats.
    Shirakura S, Karasawa A, Kubo K.
    Arzneimittelforschung; 1991 Dec 15; 41(12):1242-5. PubMed ID: 1815523
    [Abstract] [Full Text] [Related]

  • 4. Antiplatelet effects of the novel thromboxane A2 receptor antagonist sodium (E)-11-[2-(5,6-dimethyl-1-benzimidazolyl)-ethylidene]-6,11- dihydrodibenz[b,e] oxepine-2-carboxylate monohydrate.
    Karasawa A, Kawakage M, Shirakura S, Higo K, Kubo K, Ohshima E, Obase H.
    Arzneimittelforschung; 1991 Dec 15; 41(12):1230-6. PubMed ID: 1840011
    [Abstract] [Full Text] [Related]

  • 5. The pharmacological profile of the thromboxane A2 antagonist BM 13.177. A new anti-platelet and anti-thrombotic drug.
    Stegmeier K, Pill J, Müller-Beckmann B, Schmidt FH, Witte EC, Wolff HP, Patscheke H.
    Thromb Res; 1984 Aug 15; 35(4):379-95. PubMed ID: 6385334
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Actions of the novel thromboxane A2 receptor antagonist sodium (E)-11-[2-(5,6-dimethyl-1-benzimidazolyl)-ethylidene]-6,11- dihydrodibenz[b,e]oxepine-1-carboxylate monohydrate on smooth muscle preparations.
    Karasawa A, Shirakura S, Higo K, Kubo K.
    Arzneimittelforschung; 1991 Dec 15; 41(12):1237-41. PubMed ID: 1815522
    [Abstract] [Full Text] [Related]

  • 9. [The modification of the biosynthesis and effect of thromboxane A2 and prostacyclin by trapidil (Rocornal)].
    Block HU, Heinroth I, Giessler C, Pönicke K, Mentz P, Zehl U, Rettkowski W, Dunemann A, Förster W.
    Biomed Biochim Acta; 1983 Dec 15; 42(2-3):283-99. PubMed ID: 6411078
    [Abstract] [Full Text] [Related]

  • 10. Primate vascular responses to octimibate, a non-prostanoid agonist at the prostacyclin receptor.
    Merritt JE, Brown AM, Bund S, Cooper DG, Egan JW, Hallam TJ, Heagerty AM, Hickey DM, Kaumann AJ, Keen M.
    Br J Pharmacol; 1991 Jan 15; 102(1):260-6. PubMed ID: 2043927
    [Abstract] [Full Text] [Related]

  • 11. Investigation on a selective non-prostanoic thromboxane antagonist, BM 13.177, in human platelets.
    Patscheke H, Stegmeier K.
    Thromb Res; 1984 Feb 01; 33(3):277-88. PubMed ID: 6424261
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Prostaglandin H2/thromboxane A2 pathway in platelet aggregation and activity of Dahl salt-sensitive rat--a sulotroban study.
    Somova L.
    Methods Find Exp Clin Pharmacol; 1996 Jun 01; 18(5):309-13. PubMed ID: 8817465
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Pharmacological characterization of cinnamophilin, a novel dual inhibitor of thromboxane synthase and thromboxane A2 receptor.
    Yu SM, Wu TS, Teng CM.
    Br J Pharmacol; 1994 Mar 01; 111(3):906-12. PubMed ID: 8019768
    [Abstract] [Full Text] [Related]

  • 17. Combination of the thromboxane receptor antagonist, sulotroban (BM 13.177; SK&F 95587), with streptokinase: demonstration of thrombolytic synergy.
    Kopia GA, Kopaciewicz LJ, Ohlstein EH, Horohonich S, Storer BL, Shebuski RJ.
    J Pharmacol Exp Ther; 1989 Sep 01; 250(3):887-95. PubMed ID: 2528630
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. A comparative study of the involvement of the prostaglandin H2/thromboxane A2 pathway in intravascular platelet aggregation in guinea-pigs and rats.
    Mallarkey G, Smith GM.
    Br J Pharmacol; 1985 Feb 01; 84(2):425-30. PubMed ID: 3156648
    [Abstract] [Full Text] [Related]

  • 20. Thromboxane A2 analogue (U-46619) stimulates vascular PGI2 synthesis.
    Jeremy JY, Mikhailidis DP, Dandona P.
    Eur J Pharmacol; 1985 Jan 02; 107(2):259-62. PubMed ID: 3884343
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.